yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q27851656-521C862E-D7AB-4383-A583-C43D549F7E7D
Q27851656-521C862E-D7AB-4383-A583-C43D549F7E7D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851656-521C862E-D7AB-4383-A583-C43D549F7E7D
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.
P433
Q27851656-521C862E-D7AB-4383-A583-C43D549F7E7D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851656-521C862E-D7AB-4383-A583-C43D549F7E7D
rank
NormalRank
type
BestRank
Statement
P433
21
http://www.w3.org/2001/XMLSchema#string